Chromosome 4q31 locus in COPD is also associated with lung cancer

European Respiratory Journal

Volumn 36, Issue 6, 2010, Pages 1375-1382

  Young, R P ^a,b   Whittington, C F ^a   Hopkins, R J ^a   Hay, B A ^a   Epton, M J ^c   Black, P N ^a   Gamble, G D ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

^b Synergenz Biosciences Ltd   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Association study; Chronic obstructive pulmonary disease; Hedgehog interacting protein; Lung cancer; Polymorphism

Indexed keywords

HEDGEHOG INTERACTING PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CASE CONTROL STUDY; CHROMOSOME 4Q; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; FEMALE; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG CANCER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

AGED; CARRIER PROTEINS; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, PAIR 4; FEMALE; GENETIC LOCI; GLYCOPHORIN; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 78649740699     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00033310     Document Type: Article

References (53)

1. Molfino NA. Genetics of COPD. Chest 2004; 125: 1929-1940.
2. Broderick P, Wang Y, Vijayakarishnan V, et al. Deciphering the impact of common genetic variation on lung cancer risk: a genome-wide association study. Cancer Res 2009; 69: 6633-6641.
3. Kohansal R, Martinez-Camblor P, Agusti A, et al. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham Offspring Cohort. Am J Respir Crit Care Med 2009; 180: 3-10.
4. Mattson ME, Pollack ES, Cullen JW. What are the odds that smoking will kill you? Am J Pub Health 1987; 77: 425-431.
5. Young RP, Hopkins RJ, Christmas T, et al. COPD prevalence is increased in lung cancer independence of age, sex and smoking history. Eur Respir J 2009; 34: 380-386.
6. Mannino DM, Aguayo SM, Petty TL, et al. Low lung function and incident lung cancer in the United States: data from the first NHANES follow-up. Arch Int Med 2003; 163: 1475-1480.
7. Tockman MS, Anthonisen NR, Wright EC, et al. Airways obstruction and the risk for lung cancer. Ann Intern Med 1987; 106: 512-518.
8. Wilson DO, Weissfeld JL, Balkan A, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med 2008; 178: 738-744.
9. de Torres J, Bastarrika G, Wisnivesky JP, et al. Assessing the relationship between lung cancer risk and emphysema detected on low dose CT of the chest. Chest 2007; 132: 1932-1938.
10. Mortensen EM, Coleland LA, Pugh MJ, et al. Diagnosis of pulmonary malignancy after hospitalisation for pneumonia. Am J Med 2010; 123: 66-71.
11. Redline S, Tishler PV, Rosner B, et al. Genotypic and phenotypic similarities in pulmonary function among family members of adult monozygotic and dizygotic twins. Am J Epidemiol 1989; 129: 827-836.
12. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark and Finland. N Eng J Med 2000; 343: 78-85.
13. Young RP, Hopkins RJ, Hay BA, et al. Lung cancer susceptibility model based on age, family history and genetic variants. PLoS ONE 2009; 4: e5302.
14. Young RP, Hopkins RJ, Hay BA, et al. A gene based risk score for lung cancer susceptibility in smokers and ex-smokers. Postgrad Med J 2009; 85: 515-524.
15. Schwartz AG, Ruckdeschel JC. Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173: 16-22.
16. Dasari V, Gallup M, Lemjabbar H, et al. Epithelial-mesenchymal transition in lung cancer: is tobacco the "smoking gun"? Am J Respir Cell Mol Biol 2006; 35: 3-9.
17. Shintani Y, Maeda M, Chaika N, et al. Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-β signaling. Am J Respir Cell Mol Biol 2008; 38: 95-104.
18. Lee G, Walser TC, Dubinett SM. Chronic inflammation, chronic obstructive pulmonary disease, and lung cancer. Curr Opin Pulm Med 2009; 15: 303-307.
19. Sohal SS, Reid D, Soltani A, et al. Smoking has potential to initiate basement membrane disruption and epithelial mesenchymal transition in COPD. Eur Respir J 2009; 34: Suppl. 53, 2645.
20. Amos CI, Wu X, Broderick P, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008; 40: 616-622.
21. Hung RJ, McKay JD, Gaborieau V, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008; 452: 633-637.
22. Thorgeirsson TE, Geller F, Sulem P, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008; 452: 638-642.
23. Pillai SG, Ge D, Zhu G, et al. A genome-wide association study in chronic obstructive pulmonary disease (COPD): identification of two major susceptibility loci. PLoS Genet 2009; 5: e1000421.
24. Wilk JB, Chen T, Gottlieb DJ, et al. A genome-wide association study of pulmonary function measures in the Framingham Heart Study. PLoS Genet 2009; 5: e1000429.
25. Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifies five loci associated with lung function. Nat Genet 2009; 42: 36-44.
26. Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet 2009; 42: 45-52.
27. Wilk J, Walter R, Laramie J, et al. Framingham heart study genome-wide association: results for pulmonary function measures. BMC Med Genet 2007; 8: Suppl. 1, S8.
28. Frayling TM. Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 2007; 8: 657-662.
29. Stav D, Raz M. Prevalence of chronic obstructive pulmonary disease among smokers aged 45 and up in Israel. Isr Med Assoc J 2007; 9: 800-802.
30. Young RP, Hopkins RJ, Hay BA, et al. Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur Respir J 2008; 32: 1-7.
31. Lambrechts D, Buysschaert I, Zanen P, et al. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is associated with emphysema. Am J Respir Crit Care Med 2010; 181: 486-493.
32. Yang P, Yafei L, Jiang R, et al. A rigorous and comprehensive validation: common genetic variations and lung cancer. Cancer Epidemiol Bio Prev 2010; 19: 240-244.
33. Pearson TA, Manolio TA. How to interpret a genome-wide association study. JAMA 2008; 299: 1335-1344.
34. van Durme Y, Eijgelsheim M, Joos G, et al. The hedgehog interacting protein is a COPD susceptibility gene: the Rotterdam Study. Eur Respir J 2009; 36: 89-95.
35. 1-antitrypsin deficiency (PiZZ). Eur Respir J 1999; 13: 247-251.
36. Shi W, Chen F, Cardoso WV. Mechanisms of lung development: contribution to adult lung disease and relevance to chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6: 558-563.
37. Chuang PT, McMahon AP. Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 1999; 397: 617-621.
38. Cardoso WV, Lü J. Regulation of early lung morphogenesis: questions, facts and controversies. Development 2006; 133: 1611-1624.
39. Chuang PT, Kawcak T, McMahon AP. Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev 2003; 17: 342-347.
40. Watkins DN, Berman DM, Burkholder SG, et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003; 422: 313-317.
41. Lemjabbar-Alaoui H, Dasari V, Sidhu SS, et al. Wnt and hedgehog are critical mediators of cigarette smoke-induced lung cancer. PLoS ONE 2006; 1: e93.
42. Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J 1977; 1: 1645-1648.
43. Løkke A, Lange P, Scharling H, et al. Developing COPD: a 25 year follow up study of the general population. Thorax 2006; 61: 935-939. (Pubitemid 44787161)
44. Moskvina V, Holmans P, Schmidt KM, et al. Design of case- controls studies with unscreened controls. Ann Hum Genet 2005; 68: 566-576.
45. Pritchard J, Stephens M, Donnelly P. Inference of population structure frommulti-locus genotype data. Genetics 2000; 155: 945-959.
46. Thankkinstian A, Thompson JR, Minelli C, et al. Choosing between per-genotype, per-allele, and trend approaches for initial detection of gene-disease association. J App Stat 2009; 36: 633-646.
47. Yang P, Allen MS, Aubry MC, et al. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005; 128: 452-462.
48. Amos CI. Successful design and conduct of genome-wide association studies. Hum Mol Genet 2007; 16: 220-225.
49. Vestergaard J, Pedersen MW, Pedersen N, et al. Hedgehog signalling in small-cell lung cancer: frequent in vivo but a rare event in vitro. Lung Cancer 2006; 52: 281-290.
50. Minetti M, Leto TL, Malorni W. Radical generation and alterations of erythrocyte integrity as bio-indicators of diagnostic or prognostic value in COPD? Antioxid Redox Signal 2008; 10: 829-839.
51. Dickson SP, Wang K, Krantz I, et al. Rare variants create synthetic genome-wide associations. PLoS Biol 2010; 8: e1000294.
52. Young RP, Hopkins RJ, Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. Eur Respir J 2007; 30: 616-622.
53. Young RP, Hopkins R, Eaton TE. Pharmacological actions of statins: potential utility in COPD. Eur Respir Rev 2009; 18: 222-232.